Stay updated on S-600918 Efficacy in Refractory Chronic Cough Clinical Trial
Sign up to get notified when there's something new on the S-600918 Efficacy in Refractory Chronic Cough Clinical Trial page.

Latest updates to the S-600918 Efficacy in Refractory Chronic Cough Clinical Trial page
- CheckyesterdayChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as a new publication related to the study of the P2X3 receptor antagonist Sivopixant. Several previous location entries have been removed, indicating a refinement in the information presented.SummaryDifference7%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
- Check36 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.8, of the HHS Vulnerability Disclosure, replacing the previous version v2.16.6.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.0%
Stay in the know with updates to S-600918 Efficacy in Refractory Chronic Cough Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S-600918 Efficacy in Refractory Chronic Cough Clinical Trial page.